CAMC Institute is a clinical research site located in Charleston, West Virginia, United States 25304.
Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.
CAMC Institute has participated in 4 clinical trials.
Therapeutic areas: Atherosclerotic Lesions in the Aortorenal Ostium, Type 2 Diabetes, Relapsing-remitting Multiple Sclerosis.
Sponsors: Boston Scientific Corporation, Eli Lilly and Company, EMD Serono.
Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
CAMC Institute has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
CAMC Institute has 4 clinical trials on record. Their work covers Atherosclerotic Lesions in the Aortorenal Ostium, Type 2 Diabetes, Relapsing-remitting Multiple Sclerosis.
CAMC Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.